Quantitative Assessment of the Heterogeneity of PD-L1 Expression in Non-small Cell Lung Cancer (NSCLC)

IMPORTANCE: Early phase trials with monoclonal antibodies targeting PD-1/PD-L1 have demonstrated durable clinical responses in patients with NSCLC, however, current assays for the prognostic/predictive role of tumor PD-L1 expression are not standardized with respect to either quantity or distributio...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:JAMA Oncol
Hoofdauteurs: McLaughlin, Joseph, Han, Gang, Schalper, Kurt A., Carvajal-Hausdorf, Daniel, Pelakanou, Vasiliki, Rehman, Jamaal, Velcheti, Vamsidhar, Herbst, Roy, LoRusso, Patricia, Rimm, David L.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2016
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4941982/
https://ncbi.nlm.nih.gov/pubmed/26562159
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2015.3638
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items